Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IGC Pharma (IGC) Amortization of Deferred Charges (2016 - 2018)

IGC Pharma has reported Amortization of Deferred Charges over the past 8 years, most recently at $18000.0 for Q3 2018.

  • Quarterly Amortization of Deferred Charges fell 42.68% to $18000.0 in Q3 2018 from the year-ago period, while the trailing twelve-month figure was $18000.0 through Mar 2019, changed N/A year-over-year, with the annual reading at $18000.0 for FY2019, N/A changed from the prior year.
  • Amortization of Deferred Charges was $18000.0 for Q3 2018 at IGC Pharma, up from -$115000.0 in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $63616.0 in Q3 2014 and troughed at -$115000.0 in Q1 2018.
  • The 5-year median for Amortization of Deferred Charges is $34650.0 (2016), against an average of $27604.3.
  • Year-over-year, Amortization of Deferred Charges skyrocketed 356.95% in 2016 and then plummeted 545.72% in 2018.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $55200.0 in 2014, then tumbled by 123.05% to -$12726.0 in 2015, then skyrocketed by 356.95% to $32700.0 in 2016, then surged by 43.73% to $47000.0 in 2017, then plummeted by 61.7% to $18000.0 in 2018.
  • Per Business Quant, the three most recent readings for IGC's Amortization of Deferred Charges are $18000.0 (Q3 2018), -$115000.0 (Q1 2018), and $47000.0 (Q4 2017).